Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06281418Phase 3Completed
Phase 3, randomised, double-blind trial of granisetron in postoperative pain (2 arms), sponsored by Future University in Egypt. Primary endpoint: Visual Analog Scale at 24 hours. Started Feb 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06281418.